Cinctive Capital Management LP Purchases New Holdings in Ventas, Inc. $VTR

Cinctive Capital Management LP acquired a new position in Ventas, Inc. (NYSE:VTRFree Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 71,878 shares of the real estate investment trust’s stock, valued at approximately $5,031,000.

Several other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Ventas by 2.5% during the third quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock valued at $5,151,182,000 after buying an additional 1,802,515 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Ventas by 1.3% in the third quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock worth $2,078,794,000 after buying an additional 387,495 shares during the period. State Street Corp raised its holdings in shares of Ventas by 5.2% in the second quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock worth $1,781,267,000 after buying an additional 1,388,678 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Ventas by 2.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 6,601,143 shares of the real estate investment trust’s stock worth $462,002,000 after acquiring an additional 160,998 shares during the last quarter. Finally, Invesco Ltd. lifted its stake in shares of Ventas by 21.5% during the 3rd quarter. Invesco Ltd. now owns 5,847,604 shares of the real estate investment trust’s stock worth $409,274,000 after acquiring an additional 1,034,634 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Stock Up 0.6%

Shares of NYSE:VTR opened at $86.68 on Monday. The business’s 50 day moving average is $81.46 and its 200 day moving average is $76.45. The stock has a market cap of $41.17 billion, a P/E ratio of 160.52, a price-to-earnings-growth ratio of 2.11 and a beta of 0.73. Ventas, Inc. has a 52-week low of $60.15 and a 52-week high of $87.87. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTRGet Free Report) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The firm had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. During the same period last year, the firm earned $0.81 earnings per share. The company’s revenue for the quarter was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Sell-side analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be issued a $0.52 dividend. The ex-dividend date is Tuesday, March 31st. This is an increase from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. Ventas’s dividend payout ratio is presently 355.56%.

Insider Activity at Ventas

In related news, CEO Debra A. Cafaro sold 10,322 shares of the company’s stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the sale, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the transaction, the chief financial officer owned 138,434 shares in the company, valued at approximately $10,694,026.50. The trade was a 17.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 86,106 shares of company stock worth $6,931,397 over the last three months. 1.00% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Argus set a $88.00 price objective on Ventas in a research report on Tuesday, February 10th. KeyCorp lifted their target price on Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. The Goldman Sachs Group reissued a “buy” rating and set a $100.00 target price on shares of Ventas in a research note on Monday, February 9th. Scotiabank upped their price target on shares of Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a report on Monday, March 2nd. Finally, Mizuho raised their price target on shares of Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 4th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $89.00.

Get Our Latest Research Report on Ventas

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Recommended Stories

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.